These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7482326)

  • 1. [The physicochemical properties of molsidomine preparations and their efficacy in treating IHD and circulatory failure].
    Körner A; Ol'binskaia LI; Sizova ZhM; Morozov IuA
    Ter Arkh; 1995; 67(8):25-7. PubMed ID: 7482326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
    Kukushkin SK; Shamarin VM; Manoshkina EM; Berzak NV; Petrosian KIu
    Ter Arkh; 1996; 68(1):29-30. PubMed ID: 8644025
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
    Bondarenko IP; Tkachev VA
    Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
    Runovich AA; Verkhozin IA; Kuril'skaia TE; Zuev AV
    Ter Arkh; 1997; 69(9):51-2. PubMed ID: 9411828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of corvaton in the long-term ambulatory treatment of heart failure in patients with rheumatic heart lesions].
    Koshlia VI
    Ter Arkh; 1986; 58(11):51-5. PubMed ID: 3824191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particular features of photolabile substances in tablets.
    Aman W; Thoma K
    Pharmazie; 2003 Sep; 58(9):645-50. PubMed ID: 14531462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term use of the peripheral vasodilator corvaton in the polyclinic stage of rehabilitation of patients with myocardial infarction and subclinical manifestations of circulatory insufficiency (clinico-hemodynamic study)].
    Petrov DV
    Ter Arkh; 1987; 59(4):108-12. PubMed ID: 3589985
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of SIN-1 in acute left heart failure.
    Ibrahim TM; Unger PH; Sobolski J; Depelchin P; Jottrand M; Degre S
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):557-61. PubMed ID: 2488105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
    Korabel'shchikova NI; Rishko NV; Bichko MV
    Vrach Delo; 1985 Aug; (8):19-21. PubMed ID: 3840931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamics effects of continuous infusion of molsidomine and nitrates and subsequent oral medication in therapy of acute myocardial infarct].
    Honikel HJ; Fehske W
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():17-20. PubMed ID: 7968894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous molsidomine infusions in patients with unstable angina pectoris and acute myocardial infarct].
    Münzel T; Kasper W; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():30-3. PubMed ID: 7968898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of corvaton on ischemic left-ventricular damage and hemodynamic indicators in patients with acute myocardial infarction].
    Khal'fen ESh; Shvarts IL; Zolotarev VA
    Kardiologiia; 1988 Oct; 28(10):101-2. PubMed ID: 3226037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative short-term effect of once-daily molsidomine on chronic angina in general practitioners' versus cardiologists' coronary patient populations.
    Messin R
    Adv Ther; 2014 Jan; 31(1):91-106. PubMed ID: 24307221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
    Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
    Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical efficacy of the first Russian angiotensin-converting enzyme inhibitor methiopril in patients with heart failure].
    Glezer MG; Orlova LL; Titova DKh; Shvarts GIa
    Klin Med (Mosk); 1995; 73(3):49-51. PubMed ID: 8577109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.